ROSSI, Aroldo
 Distribuzione geografica
Continente #
NA - Nord America 1.862
EU - Europa 1.434
AS - Asia 1.265
SA - Sud America 241
AF - Africa 43
Continente sconosciuto - Info sul continente non disponibili 3
OC - Oceania 1
Totale 4.849
Nazione #
US - Stati Uniti d'America 1.834
SG - Singapore 543
UA - Ucraina 281
IE - Irlanda 208
BR - Brasile 191
CN - Cina 190
RU - Federazione Russa 189
SE - Svezia 184
HK - Hong Kong 166
VN - Vietnam 155
IT - Italia 144
DE - Germania 120
FI - Finlandia 92
FR - Francia 86
KR - Corea 62
GB - Regno Unito 52
IN - India 30
IQ - Iraq 24
AR - Argentina 20
TR - Turchia 19
BD - Bangladesh 14
BE - Belgio 14
CA - Canada 14
ZA - Sudafrica 12
PL - Polonia 11
VE - Venezuela 11
PK - Pakistan 10
CZ - Repubblica Ceca 9
UZ - Uzbekistan 9
LT - Lituania 8
CH - Svizzera 7
ES - Italia 7
JP - Giappone 7
MA - Marocco 7
CO - Colombia 6
NL - Olanda 6
SA - Arabia Saudita 6
TN - Tunisia 6
EC - Ecuador 5
KE - Kenya 5
MX - Messico 5
PH - Filippine 5
AT - Austria 4
PY - Paraguay 4
CG - Congo 3
ID - Indonesia 3
MY - Malesia 3
AE - Emirati Arabi Uniti 2
AL - Albania 2
BY - Bielorussia 2
DO - Repubblica Dominicana 2
EU - Europa 2
JO - Giordania 2
KG - Kirghizistan 2
KZ - Kazakistan 2
LB - Libano 2
NP - Nepal 2
RS - Serbia 2
SN - Senegal 2
SY - Repubblica araba siriana 2
TH - Thailandia 2
AM - Armenia 1
AZ - Azerbaigian 1
BG - Bulgaria 1
BO - Bolivia 1
CI - Costa d'Avorio 1
CL - Cile 1
CR - Costa Rica 1
DJ - Gibuti 1
DK - Danimarca 1
DZ - Algeria 1
EG - Egitto 1
ET - Etiopia 1
GT - Guatemala 1
HN - Honduras 1
HR - Croazia 1
IS - Islanda 1
JM - Giamaica 1
KH - Cambogia 1
LY - Libia 1
NG - Nigeria 1
NI - Nicaragua 1
NZ - Nuova Zelanda 1
PA - Panama 1
PE - Perù 1
PT - Portogallo 1
RO - Romania 1
RW - Ruanda 1
SV - El Salvador 1
UY - Uruguay 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 4.849
Città #
Singapore 366
Chandler 264
Dublin 208
Hong Kong 166
Jacksonville 154
San Mateo 134
Ashburn 119
San Jose 112
Boardman 103
Ann Arbor 68
Moscow 65
Santa Clara 65
Seoul 61
Beijing 53
Medford 53
Princeton 53
Dong Ket 49
Lauterbourg 47
The Dalles 45
Altamura 42
Munich 40
Wilmington 38
Ho Chi Minh City 33
Perugia 33
Lawrence 31
Los Angeles 30
Hanoi 29
Andover 23
Des Moines 21
Piscataway 21
Turku 21
Saint Petersburg 20
São Paulo 20
Helsinki 18
New York 18
Brussels 14
Orem 14
Woodbridge 14
Brooklyn 13
Frankfurt am Main 13
Izmir 10
Baghdad 9
Chicago 8
Johannesburg 8
Belo Horizonte 7
Columbus 7
Norwalk 7
San Paolo di Civitate 7
Tokyo 7
Brno 6
Can Tho 6
Denver 6
Houston 6
Lahore 6
Montreal 6
San Francisco 6
Shanghai 6
Auburn Hills 5
Bari 5
Boston 5
Chennai 5
Nuremberg 5
Rome 5
Uberlândia 5
Warsaw 5
Curitiba 4
Erbil 4
Florence 4
Frankfurt Am Main 4
Madrid 4
Manchester 4
Milan 4
Mumbai 4
Nairobi 4
Ninh Bình 4
Phoenix 4
Poplar 4
Asunción 3
Atlanta 3
Buenos Aires 3
Caracas 3
Catanduva 3
Charlotte 3
Council Bluffs 3
Dallas 3
Guangzhou 3
Ha Long 3
Istanbul 3
Karbala 3
London 3
Marrùbiu 3
Medellín 3
Mexico City 3
Montemesola 3
Olgiate Molgora 3
Ottawa 3
San Diego 3
Santo André 3
Tashkent 3
Toronto 3
Totale 2.966
Nome #
Botulinum toxin versus lidocaine in the treatment of myofacial pain: a double blind randomized study 131
Early detection of substantia nigra changes in Parkinson's disease: a magnetization transfer ratio (MTR) study 127
Disturbi dell'equilibrio nei pazienti con cefalea primaria: entità reale o soggettiva? Valutazione qualitativa e quantitativa mediante stabilometria statica - Atti XVI Conresso Nazionale "Cefalee ed età della vita" 126
Balance disorders in headache patients: evaluation by computerized static stabilometry 125
A magnetization transfer study of mild and advanced Parkinson's disease. 124
A multidiscilinary method for a successful aging 122
Acute dystonia induced by the combination of midodrine and perphenazine. 120
Clinical aspects and management of levodopa-induced dyskinesia. 120
Cerebrospinal fluid lysosomal enzymes and α-synuclein in Parkinson's disease. 119
Cerebrospinal fluid biomarkers in Parkinson's disease with dementia and dementia with Lewy bodies. 113
Skin biopsy: a new diagnostic tool for autonomic dysfunctions in Parkinson's disease? 111
Botulinum A toxin modulates afferent fibers in neurogenic detrusor overactivity 110
Cerebrospinal fluid Tau/α-synuclein ratio in Parkinson's disease and degenerative dementias. 109
Botulinum Toxin A Modulates Afferent Fibers in Neurogenic Detrusor Overactivity 109
Demenza e pseudodemenza: utilità dei criteri diagnostici 108
Creatine kinase BB activity in serum of patients with acute stroke: correlation with the severity of brain damage. 108
Neurobiotica: studio multidisciplinare per il recupero delle funzioni cerebrali 105
Elevated beta-N-acetylhexosaminidase activity in focal dystonia fibroblasts 105
A unique association of Marfan syndrome with craniofacial hypoplasia, oligophrenia and severe microphthalmia. 104
Botulinum Toxin A for Overactive Bladder and Detrusor Muscle Overactivity in Patients With Parkinson's Disease and Multiple System Atrophy 100
A novel spinocerebellar ataxia type 15 family with involuntary movements and cognitive decline 97
Tossina botulinica: nuove possibilità di impiego 96
Rapid effect of levetiracetam in a case of juvenile myoclonic epilepsy 96
Prevalence of essential tremor in the territory of Lake Trasimeno, Italy: results of a population-based study 95
CSF Biomarkers in Parkinson's disease 93
Lysosomial hydrolase in cerebrospinal fluid from subjects with Parkinson's disease 92
A young patient with type C multiple system atrophy and hereditary hemochromatosis. 92
Shapiro's syndrome: Defining the clinical spectrum of the spontaneous paroxysmal hypothermia syndrome. 91
Levodopa-induced breathing, cognitive and behavioral changes in Parkinson's disease 90
Entacapone Reduces Cortical Activation in Parkinson's Disease with Wearing-Off: A f-MRI Study 90
Botulinum toxin type A in patients with Parkinson's disease and refractory overactive bladder. 84
Effect of MTHFR polymorphisms on hyperhomocysteinemia in levodopa-treated Parkinsonian patients. 82
Elevated beta-N-acetylhexosaminidase activity in focal dystonia fibroblasts 82
Modificazioni del nervo sciatico nel ratto indotte da diete lipidiche. 81
The endocannabinoid system in Parkinson's disease. 80
The Brain Dopaminergic System and Hyperthermia: The Neuroleptic Malignant Syndrome and The Parkinsonism-hyperpyrexia Syndrome 80
Parkinsonism and cognitive impairment following chronic exposure to potassium cyanide. 79
Hyperhomocysteinemia recurrence in levodopa-treated Parkinson's disease patients. 79
Validation of the Italian version of the Movement Disorder Society-Unified Parkinson's Disease Rating Scale. 79
The validity and reliability of the Italian Olfactory Identification Test (IOIT) in healthy subjects and in Parkinson's disease patients. 78
Role of Lysosomal Enzymes in Parkinson’s Disease: Lesson from Gaucher’s Disease 78
Occipital pseudoaneurysm as a complication of extension channel placement for DBS in Parkinson's disease. 76
Differential role of CSF alpha-synuclein species, tau, and Aβ42 in Parkinson's Disease. 75
Hot water epilepsy and Mccune-Albright syndrome: a case report. 74
Somministrazione intradetrusoriale di tossina botulinica A in pazienti con iperattività detrusoriale e vescica iperattiva dovute a M. di Parkinson ed atrofia multi- sistemica. 74
Botulinum A toxin intravesical injection in patients with Parkinson’ s disease and Multiple System Atrophy with overactive bladder syndrome and detrusor overactivity. 74
Multimodal use of computed tomography in early acute stroke 73
Vomiting due to intravenous levetiracetam in a case of Creutzfeldt-Jakob disease. 71
Complexity of motor sequences and cortical reorganization in Parkinson's disease: a functional MRI study. 68
Disturbi dell'equilibrio in pazienti con mcefalea: diversi meccanismi patogenetici? 66
Tappe dello sviluppo cerebrale in relazione alla disponibilità di nutrienti a partire dall'australopiteco 63
Il trattamento della sclerosi multipla 61
Iodine- Iodine-123-N-omega-fluoropropyl fluoropropyl fluoropropyl-2beta-carbomethoxy carbomethoxy carbomethoxy-3beta-(4- iodophenyl)- iodophenyl)-nortropane nortropane nortropane brain SPET with brain SPET with brain SPET with semiquantitative analysis in semiquantitative analysis in Parkinson’s disease as evaluated by support vector machine classifier: diagnostic performance and influence of age diagnostic performance and influence of age 49
Totale 4.934
Categoria #
all - tutte 19.993
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 19.993


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021135 0 0 0 0 0 0 0 0 0 21 56 58
2021/2022428 13 95 12 28 14 1 2 134 4 9 51 65
2022/2023787 59 145 14 71 68 84 0 33 277 3 23 10
2023/2024313 23 22 17 10 2 4 46 14 53 7 49 66
2024/2025791 18 72 26 49 103 39 27 27 154 37 172 67
2025/20261.576 136 135 98 254 225 151 250 51 158 118 0 0
Totale 4.934